Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CDIO | US
0.05
2.73%
Healthcare
Biotechnology
30/06/2024
13/04/2026
1.88
1.99
1.99
1.85
Cardio Diagnostics Holdings Inc. an artificial intelligence-powered precision cardiovascular medicine company develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events including heart attacks; and PrecisionCHD an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago Illinois.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
110.8%1 month
106.3%3 months
254.5%6 months
197.6%-
-
2.10
0.28
0.22
-22.48
151.27
-
-8.22M
57.53M
57.53M
-
-16.30K
-
356.20
-293.27
1.55
13.77
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.57
Range1M
1.36
Range3M
6.94
Rel. volume
0.41
Price X volume
167.01K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| InflaRx N.V | IFRX | Biotechnology | 1.07 | 63.01M | 7.00% | n/a | 0.00% |
| QNCX | QNCX | Biotechnology | 1.41 | 61.02M | 3.45% | n/a | 30.62% |
| Equillium Inc | EQ | Biotechnology | 1.7 | 60.22M | -5.56% | n/a | 2.71% |
| VANI | VANI | Biotechnology | 1.05 | 58.02M | 0.96% | n/a | 84.10% |
| ImmuCell Corporation | ICCC | Biotechnology | 7.11 | 55.69M | 0.49% | n/a | 67.52% |
| PEPG | PEPG | Biotechnology | 1.69 | 55.08M | 3.05% | n/a | 12.52% |
| THL Credit Inc. 6.75% Notes du | TCRX | Biotechnology | 1.02 | 54.03M | -2.86% | n/a | 35.68% |
| TPST | TPST | Biotechnology | 2.14 | 53.94M | 4.39% | n/a | 119.58% |
| Sangamo Therapeutics Inc | SGMO | Biotechnology | 0.257 | 53.51M | 2.31% | n/a | 122.82% |
| OKYO Pharma Limited | OKYO | Biotechnology | 1.53 | 51.77M | 1.32% | n/a | -107.88% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 10.4 | 15.84M | -11.56% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.8799 | 12.86M | -18.53% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6 | 11.59M | -0.17% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.33 | 3.40M | -0.75% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2276 | 2.17M | -10.25% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.07 | 1.14M | -0.96% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -22.48 | 0.53 | Cheaper |
| Ent. to Revenue | 151.27 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.10 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 254.45 | 72.80 | Riskier |
| Debt to Equity | 0.28 | -1.23 | Expensive |
| Debt to Assets | 0.22 | 0.25 | Par |
| Market Cap | 57.53M | 3.66B | Emerging |